DATSUN
voted
When Cathie Wood reflects on her career, she attributes any professional marginalization she experiences to her contrarian views rather than her gender, she told CNBC in a recent interview.
By being unwavering and publicly vocal about her convictions, Wood gives critics ample opportunity to take aim at her unique strategies.
“Other people say that I am attacked in the media because I’m a woman. I don’t th...
By being unwavering and publicly vocal about her convictions, Wood gives critics ample opportunity to take aim at her unique strategies.
“Other people say that I am attacked in the media because I’m a woman. I don’t th...
17
4
DATSUN
commented on
DATSUN
commented on
$NIO Inc (NIO.US)$ Is it good news or bad news to go public in an introduction format? Can friends who understand explain?
Translated
2
DATSUN
commented on
DATSUN
commented on
$NIO Inc (NIO.US)$ The institution sold at $48.15. As retail investors, it is best not to chase after higher prices.
Translated
1
3
DATSUN
voted
$NIO Inc (NIO.US)$
There may be a few companies fighting to gain market share in China. I have faith that NIO will be one of the leading company taking a huge portion of the EV market.
What do you think?
There may be a few companies fighting to gain market share in China. I have faith that NIO will be one of the leading company taking a huge portion of the EV market.
What do you think?
11
2
DATSUN
commented on
DATSUN
voted
Key Takeaway:
● We are now informed that the FDA expects to assign our file to a reviewer and place it under review no later than April 15.
● A key business objective for us this year is to complete the IDE submission for this 365-day sensor, all subject to the availability of the FDA review group.
● We believe that we are now well positioned to address the top unmet need in the large and growing CGM market.
...
● We are now informed that the FDA expects to assign our file to a reviewer and place it under review no later than April 15.
● A key business objective for us this year is to complete the IDE submission for this 365-day sensor, all subject to the availability of the FDA review group.
● We believe that we are now well positioned to address the top unmet need in the large and growing CGM market.
...
6